The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling release_7qv7z22wcze3blyb4nyqlvqtdm

by Maricica Pacurari, Ramzi Kafoury, Paul B. Tchounwou, Kenneth Ndebele

Published in International Journal of Inflammation by Hindawi Limited.

Volume 2014p1-13 (2014)


The RAAS through its physiological effectors plays a key role in promoting and maintaining inflammation. Inflammation is an important mechanism in the development and progression of CVD such as hypertension and atherosclerosis. In addition to its main role in regulating blood pressure and its role in hypertension, RAAS has proinflammatory and profibrotic effects at cellular and molecular levels. Blocking RAAS provides beneficial effects for the treatment of cardiovascular and renal diseases. Evidence shows that inhibition of RAAS positively influences vascular remodeling thus improving CVD outcomes. The beneficial vascular effects of RAAS inhibition are likely due to decreasing vascular inflammation, oxidative stress, endothelial dysfunction, and positive effects on regeneration of endothelial progenitor cells. Inflammatory factors such as ICAM-1, VCAM-1, TNF<mml:math xmlns:mml="" id="M1"><mml:mrow><mml:mo>α</mml:mo></mml:mrow></mml:math>, IL-6, and CRP have key roles in mediating vascular inflammation and blocking RAAS negatively modulates the levels of these inflammatory molecules. Some of these inflammatory markers are clinically associated with CVD events. More studies are required to establish long-term effects of RAAS inhibition on vascular inflammation, vascular cells regeneration, and CVD clinical outcomes. This review presents important information on RAAS's role on vascular inflammation, vascular cells responses to RAAS, and inhibition of RAAS signaling in the context of vascular inflammation, vascular remodeling, and vascular inflammation-associated CVD. Nevertheless, the review also equates the need to rethink and rediscover new RAAS inhibitors.
In application/xml+jats format

Archived Files and Locations

application/pdf  722.3 kB
file_ixgu7p4go5fgzdfstrgqeeqsfy (aggregator) (webarchive)
application/pdf  1.4 MB
file_l7twn5mwojarva77rbfoyozoye (webarchive) (publisher)
Read Archived PDF
Type  article-journal
Stage   published
Year   2014
Language   en ?
DOI  10.1155/2014/689360
PubMed  24804145
PMC  PMC3997861
Wikidata  Q21284671
Journal Metadata
Open Access Publication
In Keepers Registery
ISSN-L:  2042-0099
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 294f27e7-1d9d-41d3-a584-9cd69f915f1b